BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 26327604)

  • 1. Quantifying signaling pathway activation to monitor the quality of induced pluripotent stem cells.
    Makarev E; Fortney K; Litovchenko M; Braunewell KH; Zhavoronkov A; Atala A
    Oncotarget; 2015 Sep; 6(27):23204-12. PubMed ID: 26327604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptome Profiling Reveals Degree of Variability in Induced Pluripotent Stem Cell Lines: Impact for Human Disease Modeling.
    Schuster J; Halvardson J; Pilar Lorenzo L; Ameur A; Sobol M; Raykova D; Annerén G; Feuk L; Dahl N
    Cell Reprogram; 2015 Oct; 17(5):327-37. PubMed ID: 26348590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficient hematopoietic redifferentiation of induced pluripotent stem cells derived from primitive murine bone marrow cells.
    Pfaff N; Lachmann N; Kohlscheen S; Sgodda M; Araúzo-Bravo MJ; Greber B; Kues W; Glage S; Baum C; Niemann H; Schambach A; Cantz T; Moritz T
    Stem Cells Dev; 2012 Mar; 21(5):689-701. PubMed ID: 21732815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Directed neuronal differentiation of mouse embryonic and induced pluripotent stem cells and their gene expression profiles.
    Chen X; Gu Q; Wang X; Ma Q; Tang H; Yan X; Guo X; Yan H; Hao J; Zeng F
    Int J Mol Med; 2013 Jul; 32(1):25-34. PubMed ID: 23652807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of the early and late responder genes during the generation of induced pluripotent stem cells from mouse fibroblasts.
    Park J; Kwon YW; Ham S; Hong CP; Seo S; Choe MK; Shin SI; Lee CS; Kim HS; Roh TY
    PLoS One; 2017; 12(2):e0171300. PubMed ID: 28152015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome wide profiling of dopaminergic neurons derived from human embryonic and induced pluripotent stem cells.
    Momčilović O; Liu Q; Swistowski A; Russo-Tait T; Zhao Y; Rao MS; Zeng X
    Stem Cells Dev; 2014 Feb; 23(4):406-20. PubMed ID: 24074155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reprogramming Methods Do Not Affect Gene Expression Profile of Human Induced Pluripotent Stem Cells.
    Trevisan M; Desole G; Costanzi G; Lavezzo E; Palù G; Barzon L
    Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28117672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolome Profiling of Partial and Fully Reprogrammed Induced Pluripotent Stem Cells.
    Park SJ; Lee SA; Prasain N; Bae D; Kang H; Ha T; Kim JS; Hong KS; Mantel C; Moon SH; Broxmeyer HE; Lee MR
    Stem Cells Dev; 2017 May; 26(10):734-742. PubMed ID: 28346802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiation of primordial germ cells from induced pluripotent stem cells of primary ovarian insufficiency.
    Leng L; Tan Y; Gong F; Hu L; Ouyang Q; Zhao Y; Lu G; Lin G
    Hum Reprod; 2015 Mar; 30(3):737-48. PubMed ID: 25586786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamic transcriptional and epigenomic reprogramming from pediatric nasal epithelial cells to induced pluripotent stem cells.
    Ji H; Zhang X; Oh S; Mayhew CN; Ulm A; Somineni HK; Ericksen M; Wells JM; Khurana Hershey GK
    J Allergy Clin Immunol; 2015 Jan; 135(1):236-44. PubMed ID: 25441642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Huntington disease iPSCs show early molecular changes in intracellular signaling, the expression of oxidative stress proteins and the p53 pathway.
    Szlachcic WJ; Switonski PM; Krzyzosiak WJ; Figlerowicz M; Figiel M
    Dis Model Mech; 2015 Sep; 8(9):1047-57. PubMed ID: 26092128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cartilage tissue engineering identifies abnormal human induced pluripotent stem cells.
    Yamashita A; Liu S; Woltjen K; Thomas B; Meng G; Hotta A; Takahashi K; Ellis J; Yamanaka S; Rancourt DE
    Sci Rep; 2013; 3():1978. PubMed ID: 23760219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ovine induced pluripotent stem cells are resistant to reprogramming after nuclear transfer.
    German SD; Campbell KH; Thornton E; McLachlan G; Sweetman D; Alberio R
    Cell Reprogram; 2015 Feb; 17(1):19-27. PubMed ID: 25513856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved hematopoietic differentiation of primate embryonic stem cells by inhibition of the PI3K-AKT pathway under defined conditions.
    Nii T; Marumoto T; Kohara H; Yamaguchi S; Kawano H; Sasaki E; Kametani Y; Tani K
    Exp Hematol; 2015 Oct; 43(10):901-911.e4. PubMed ID: 26073521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Granulosa cell-derived induced pluripotent stem cells exhibit pro-trophoblastic differentiation potential.
    Chuang CY; Huang MC; Chen HF; Tseng LH; Yu CY; Stone L; Huang HP; Ho HN; Kuo HC
    Stem Cell Res Ther; 2015 Feb; 6(1):14. PubMed ID: 25889179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current progress and potential practical application for human pluripotent stem cells.
    Philonenko ES; Shutova MV; Chestkov IV; Lagarkova MA; Kiselev SL
    Int Rev Cell Mol Biol; 2011; 292():153-96. PubMed ID: 22078961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Keratinocyte growth factor and dexamethasone plus elevated cAMP levels synergistically support pluripotent stem cell differentiation into alveolar epithelial type II cells.
    Schmeckebier S; Mauritz C; Katsirntaki K; Sgodda M; Puppe V; Duerr J; Schubert SC; Schmiedl A; Lin Q; Paleček J; Draeger G; Ochs M; Zenke M; Cantz T; Mall MA; Martin U
    Tissue Eng Part A; 2013 Apr; 19(7-8):938-51. PubMed ID: 23176317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired neural differentiation potency by retinoic acid receptor-α pathway defect in induced pluripotent stem cells.
    Hou PS; Huang WC; Chiang W; Lin WC; Chien CL
    Cell Reprogram; 2014 Dec; 16(6):467-76. PubMed ID: 25364979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of a teratogenic transcriptome-based predictive test based on human embryonic versus inducible pluripotent stem cells.
    Shinde V; Perumal Srinivasan S; Henry M; Rotshteyn T; Hescheler J; Rahnenführer J; Grinberg M; Meisig J; Blüthgen N; Waldmann T; Leist M; Hengstler JG; Sachinidis A
    Stem Cell Res Ther; 2016 Dec; 7(1):190. PubMed ID: 28038682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishment and gene expression analysis of disease-derived induced pluripotent stem cells of scleroderma.
    Wang Z; Nakamura K; Jinnin M; Kudo H; Goto M; Era T; Kira T; Nakashima T; Fukushima S; Ihn H
    J Dermatol Sci; 2016 Nov; 84(2):186-196. PubMed ID: 27510999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.